Web Content Management
PRODUCTS
-
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC ServicesFast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.
-
ProPharma has deep expertise across all signal detection and management activities, including validation, prioritization, and assessment using data from a wide range of sources that are relevant for signal detection for the individual product(s). We are also fully trained and experienced in the EudraVigilance Data Analysis System (EVDAS) functionality and can support MAHs to comply with their obligations for signal detection and management. We leverage our robust knowledge to select the most efficient and effective method(s) for each product that is compliant with legislative requirements.
-
As a top Clinical Research Organization, ProPharma brings over 20 years of experience, innovation, personalization, and adaptability to Sponsors’ studies and research.
-
Industry leader in preclinical safety assessments across various therapeutic areas. 30+ years of experience in full range of in vivo non-GLP and GLP studies in both rodent and non-rodent species.
-
The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.
Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.
WHITE PAPERS AND CASE STUDIES
-
Implementing A Disaster Recovery Plan
When facing a malfunction, having an effective disaster recovery plan can make the difference between a swift fix, and losing your samples and time.
-
Advancements In Microbial Manufacturing Of Biopharmaceuticals
Dive into the evolution and future potential of microbial manufacturing in the biopharmaceutical industry to discover how digital tools can revolutionize development and production processes.
-
Why A Leading Manufacturing Partner Chose NeoTOP Packaging Machines
Learn how a leading CDMO partnered with Körber to quickly deploy a high-speed packaging solution to meet tight production deadlines in the face of a global pandemic.
-
Sustainable Solutions For Medical Devices
Explore how medical device companies aim to balance patient safety with environmental stability by offering bio-based UHMWPE, which reduces carbon footprints by up to 70%.
-
Leaks Go Acoustic: How Rogers Water Reduced Waste And Built Resiliency
Read how Rogers Water Utility (RWU) took action to mitigate constant leaks in their distribution system, which made it challenging to maintain volume in the eastern district’s water tower.
-
Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer
Discover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.
-
Digital Transformation - The Power Of Your Data
Discover how you can circumvent numerous recirculations during the ultrafiltration process step, boost downstream bioprocess yield, and identify and resolve process inefficiencies.
-
Analytics–Powered Approach To Patient Recruitment Strategy
In a Phase 3 psychiatry trial, a pharmaceutical company partnered with Signant to revolutionize patient recruitment through data-driven site selection using PureSignal Analytics.
-
Improving Patient Health And Safety: Medical Affairs
A medical affairs department needed leaders with scientific and project management expertise. With no time for training or risk tolerance, a consultant was hired to align activities with development and launch plans.
-
Rapid Startup Phase 1 Cardiomyopathy CRISPR Gene Therapy
Hereditary transthyretin amyloidosis (ATTRv) is very rare, prompting a Phase 1 trial of in vivo CRISPR/Cas9 gene editing to reduce mutant protein and stop cardiomyopathy progression.
-
Why Early Market Access Planning Is Crucial In CGT Commercial Strategy
Bringing cell and gene therapies (CGTs) to market and ensuring patient access is a complex process. Discover how developing a market access strategy and partnering with experts can help.
-
Revolutionizing Wastewater Management In Four Cities Through Water Mixing
Historically, lift station operators have turned to chemical treatments as the primary means of managing grease buildup. However, these methods carry inherent drawbacks.
NEWS
-
isolved Launches Benefits Guidance To Help Employers Simplify Enrollment And Support Smarter Employee Decisions9/16/2025
isolved®, a provider of human capital management (HCM) solutions that help organizations recruit, retain and elevate their workforce, today announced the launch of isolved Benefits Guidance, a new solution that helps employees make smarter benefit selections while easing administrative strain on HR teams.
-
Azenta Launches Fully Networked 2D-Coded Tube Readers11/17/2025
Azenta Life Sciences announces the launch of its next-generation camera-based tube readers - Mirage Connect and Cube Connect - ushering in a new era of networked, cryo-capable sample management systems.
-
Quidelortho And Bühlmann Laboratories AG Announce Availability Of Fecal Calprotectin (fCAL®) Turbo And Fecal Pancreatic Elastase (fPELA®) Turbo Assays On Vitros™ Systems As A Microtip™ Partnership Assay (Mpa)7/14/2025
QuidelOrtho Corporation ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's VITROS Systems as an MPA.
-
Yorkshire Water Models Sewer Data Availability10/2/2025
An ongoing project with Yorkshire Water is taking a proactive approach to combined sewer overflow (CSO) management, shifting from reactive responses to preventative measures - crucial for both regulatory compliance and environmental protection.
-
Resi Media Launches Studio AI, Transforming Video Content Creation With AI-Powered Automation For Ministry Teams11/11/2025
Resi Media, a leading end-to-end solution for online and multisite video streaming, announces the launch of Studio AI, a new solution that streamlines video content creation by combining AI-driven automation with seamless video editing tools.